What to expect in the MARAVAI LIFESCIENCES HOLDINGS, INC. interview process

Based on information found online, Maravai LifeSciences Holdings, Inc. is a publicly traded biotechnology research and pharmaceuticals company founded in 2014 and headquartered in San Diego, California (specifically at 10770 Wateridge Circle). Public records indicate that the company operates through a portfolio of specialized companies—including TriLink BioTechnologies, Glen Research, Alphazyme, and Cygnus Technologies—to supply nucleic acid products, custom enzymes, and biologics safety testing solutions.

Workforce intelligence data shows that Maravai has undergone a significant reduction in headcount, dropping from 692 employees in 2023 down to a global workforce ranging between approximately 435 and 467 employees. Despite this broader multi-year contraction, hiring signals indicate that the company has active job openings, with active job postings showing an increase of 18.2% in 2026 compared to the previous year.

From a governance and operational standpoint, recent corporate reports highlight that the company has focused on expanding its Good Manufacturing Practice (GMP) capabilities, launching an Analytical Sciences Center of Excellence, and introducing site-level ethics liaison programs alongside enhanced greenhouse gas accounting initiatives. The company's operations span the United States, Canada, and international locations, offering specialized tools and services for PCR, next-generation sequencing, gene editing, and bioprocess impurity detection.